Pfizer, J&J vaccine rollout in India could take a few months

US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines authorised by major global regulators. While J&J is keen to enter India and has recently held preliminary discussions to apply for emergency use authorisation, Pfizer withdrew from the race in February due to regulatory issues.